QHP Capital completed the investment in Vector Clinical Trials.

QHP Capital, an investment company, completed the investment in Vector Clinical Trials, a dedicated clinical research site network. Financial terms were not disclosed. “Vector’s model starts with the community. By partnering with physicians where patients already receive care, Vector consistently delivers speed, quality, and access – especially for populations historically underrepresented in research. We’re excited to back Dr. Bobby and invest behind building sites with real scale that serve their communities while meeting sponsors’ enrollment and data-quality needs,” Michael Sorensen, QHP Capital Partner.